Methylated RNA Immunoprecipitation Sequencing Reveals the m6A Landscape in Oral Squamous Cell Carcinoma. (15th July 2022)

• Record Type: Journal Article
• Authors: Wang, Xi; Wu, Jie; Zhang, Leyu; Zhao, Wei; Deng, Jiayin
• Other Names: Huang Jingang Academic Editor.
• Is Part Of: Journal of immunology research. Volume 2022(2022)
• Publication Date: 2022-07-15
• Subjects: Immunology -- Periodicals; Immunology -- Research -- Periodicals; 616.07905
• DOI: 10.1155/2022/7277583
• Languages: English
• ISSNs: 2314-8861

Abstract

Abstract : N6-methyladenosine (m 6 A) is the most common epigenetic modification existing in eukaryocyte transcripts. However, genes related to m 6 A modification in oral squamous cell carcinoma (OSCC) are still unclear. Here, methylated RNA immunoprecipitation sequencing (MeRIP-Seq) was performed to map the m6A landscape in OSCC and corresponding controls. The m 6 A peaks are always distributed in the junction of the 3′ -untranslated regions (3′ -UTRs) and the coding sequences (CDS) of mRNAs, as well as the entire genome of long noncoding RNA (lncRNA). Furthermore, enrichment analysis showed that differentially methylated genes were significantly enriched in NF-kappa B signaling pathway, Hedgehog signaling pathway, etc. In summary, our findings reveal the landscape of m 6 A modification on mRNAs and lncRNAs in OSCC, which may provide key clues for the precision-targeted therapy of OSCC.